Dublin, June 15, 2021 (GLOBE NEWSWIRE) -- The "Molecular Biology Enzymes & Kits & Reagents Market by Product (Kit, Reagent, Enzyme), Application (PCR, Sequencing, Epigenetic, Synthetic Biology), End user (Research Institutes, Pharma & Biotech Company, Hospitals) and Region - Global Forecast to 2026" report has been added to ResearchAndMarkets.com's offering.
The global molecular biology enzymes and kits & reagents market is projected to USD 29.7 billion by 2026 from USD 15.3 billion in 2021, at a CAGR of 14.2% during the forecast period.
The rising number of genome projects coupled with reducing genetic analysis costs helps advance research in various domains, such as disease treatment, personalized medicine, and microbial genetics. These processes require the use of various molecular biology enzymes and reagents and are thus expected to drive the molecular biology enzymes and kits & reagents market. However, factors such as limited reimbursements for genetic testing are likely to hinder the growth of this market.
The kits & reagents segment accounted for the highest growth rate in the molecular biology enzymes and kits & reagents market, by product, during the forecast period
The molecular biology enzymes and kits & reagents market is segmented into enzymes and kits & reagents. The kits & reagents segment accounted for the largest share of 85.9% of the global molecular biology enzymes and kits & reagents market in 2020. The large share of this segment can primarily be attributed to the repeat purchase of these single-use products. This segment is also expected to grow at the highest rate owing to its wide applications by pharmaceutical & biotechnology companies.
Polymerase chain reaction (PCR) segment accounted for the largest share
Based on applications, the global molecular biology enzymes and kits & reagents market is segmented into polymerase chain reaction (PCR), sequencing, cloning, epigenetics, restriction digestion, synthetic biology, and other applications (mutagenesis, in vitro transcription, and molecular labeling & detection).
The polymerase chain reaction (PCR) segment accounted for the largest share of the molecular biology enzymes and kits & reagents market in 2020, mainly due to the low cost of PCR equipment, the extensive use of PCR equipment by a majority of end users, and the increasing use of PCR for molecular diagnostic assays in hospitals and clinics.
Asia Pacific: The fastest-growing region in the molecular biology enzymes and kits & reagents market
The molecular biology enzymes and kits & reagents market is segmented into North America, Europe, Asia Pacific, RoW. The molecular biology enzymes and kits & reagents market in the Asia Pacific region is expected to grow at the highest CAGR during the forecast period. Growth in the APAC market is driven by increasing government interest in the biomedical & biotechnology industries, the presence of bio-clusters in India and China, and the growing outsourcing of clinical research activities to Asian countries.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Molecular Biology Enzymes and Kits & Reagents Market Overview
4.2 North America: Molecular Biology Enzymes and Kits & Reagents Market
4.3 Molecular Biology Enzymes and Kits & Reagents Market, by Application
4.4 Molecular Biology Enzymes and Kits & Reagents Market: Geographic Growth Opportunities
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Growing Number of Genome Projects
5.2.1.2 Technological Advancements in the Life Science Industry
5.2.1.3 Rising Incidence of Genetic Disorders
5.2.2 Restraints
5.2.2.1 Limited Reimbursements for Genetic Testing
5.2.3 Opportunities
5.2.3.1 Increased Use of Personalized Medicine
5.2.3.2 R&D Investments Offer Significant Opportunities for the Market
5.3 COVID-19 Impact Analysis
5.4 Technology Analysis
5.5 Value Chain Analysis
5.6 Supply Chain Analysis
5.7 Porters Five Forces Analysis
5.7.1 Threat from New Entrants
5.7.2 Threat from Substitutes
5.7.3 Bargaining Power of Suppliers
5.7.4 Bargaining Power of Buyers
5.7.5 Intensity of Competition Rivalry
5.8 Regulatory Landscape
5.9 Pricing Analysis
5.10 Patent Analysis
6 Molecular Biology Enzymes and Kits & Reagents Market, by Product
7 Molecular Biology Enzymes and Kits & Reagents Market, by Application
8 Molecular Biology Enzymes and Kits & Reagents Market, by End-user
9 Molecular Biology Enzymes and Kits & Reagents Market, by Region
10 Competitive Landscape
11 Company Profiles
11.1 Major Players
11.1.1 Thermo Fisher Scientific, Inc.
11.1.2 Merck KGaA
11.1.3 Promega Corporation
11.1.4 New England Biolabs
11.1.5 Illumina, Inc.
11.1.6 Takara Bio, Inc.
11.1.7 Qiagen N.V.
11.1.8 Agilent Technologies, Inc.
11.1.9 F. Hoffmann-La Roche Ltd.
11.1.10 Bio Basic Inc.
11.1.11 Jena Bioscience GmbH
11.1.12 Molecular Biology Resources, Inc.
11.1.13 Bio-Rad Laboratories, Inc.
11.2 Other Players
11.2.1 Zymo Research Corporation
11.2.2 Integrated Dna Technologies, Inc.
11.2.3 Lgc Biosearch Technologies
11.2.4 Nzytech, Lda. - Genes & Enzymes
11.2.5 Lucigen Corporation
11.2.6 Mobitec GmbH
11.2.7 Genekam Biotechnology Ag
11.2.8 Aldevron
11.2.9 Randox Laboratories Ltd.
11.2.10 Ads Biotec
11.2.11 Hangzhou Matridx Biotechnology Co. Ltd.
11.2.12 Goldsite Diagnostics Inc.
12 Appendix
For more information about this report visit https://www.researchandmarkets.com/r/fq8xfe